{"id":1041,"date":"2020-04-04T18:28:39","date_gmt":"2020-04-04T11:28:39","guid":{"rendered":"http:\/\/kinaseinhibitorlibrary.com\/?p=1041"},"modified":"2022-01-13T16:35:49","modified_gmt":"2022-01-13T09:35:49","slug":"impact-cell-antigens-organ-specific-species-specific","status":"publish","type":"post","link":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/2020\/04\/04\/impact-cell-antigens-organ-specific-species-specific\/","title":{"rendered":"which have an impact on cell The antigens might be organ specific rather than species-specific"},"content":{"rendered":"

In our experiment, inner ear antigens with molecular weights in the 25-35 kDa, 35-48 kDa, and 57-63 kDa ranges were detected. These antigens are likely to be similar to those detected in previous studies. Although the identity of these antigens can be conjectured from the antigens with similar molecular weight detected in the Protoarray experiment as suggested in the result, it should be further studied using immunoprecipitation of patient serum and inner ear tissues followed by mass spectrometry of the corresponding protein bands. We divided the mouse inner ear tissue into cochlear and vestibular tissues and investigated whether an antigen-antibody reaction between these tissues and patient serum occurred. In contrast, previous studies tended to use whole inner ear tissue. We found that each antigen reacted with the serum differently; samples of patient serum could react with the cochlear tissue, with the vestibular tissue, or with both. Clinically, cochlear and vestibular symptoms in Meniere’s disease are different for each patient. In general, vestibular symptoms tend to coincide with cochlear symptoms. However, the progression of each cochlear and vestibular symptom and function varies from patient to patient. The varying antigen-antibody Remdesivir GS-5734<\/a> reactions observed in each tissue may be associated with the varying clinical features of the disease. Because a variety of inner ear antigens could react with patient serum, it appears that multiple target antigens and autoantibodies may be responsible for the autoimmune reaction associated with Meniere’s disease. The 1-DE findings examining the protein composition of the ES luminal fluid of patients with Meniere’s disease also support this hypothesis: the distribution of bands was different in the 3 patients, suggesting that the protein composition of the ES luminal fluid of each patient was different and that different antibodies or inflammatory materials are present in each patient. In contrast, the continued use of MTX has being associated with oxidative imbalance, which may cause multi-organ toxicities, including hepato-, neuro-, lung- and nephrotoxicity and testicular damage. Investigations suggest that oxidative stress caused by MTX involves decreasing in some antioxidant enzymes as glutathione peroxidase, glutathione reductase, catalase and superoxide dismutase, increasing of lipoperoxidation and reactive oxygen species levels, as well as apoptosis induction. Despite the fact that the clinical response to MTX and its adverse effects exhibit marked interpatient variability indicating pharmacogenetic effects, the influence of antioxidant gene polymorphisms on MTX efficacy and toxicity is not well studied. Human beings present genetic polymorphisms in antioxidant enzymes.<\/p>\n","protected":false},"excerpt":{"rendered":"

In our experiment, inner ear antigens with molecular weights in the 25-35 kDa, 35-48 kDa, and 57-63 kDa ranges were detected. These antigens are likely to be similar to those detected in previous studies. Although the identity of these antigens can be conjectured from the antigens with similar molecular weight detected in the Protoarray experiment … Continue reading which have an impact on cell The antigens might be organ specific rather than species-specific<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1041"}],"collection":[{"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/comments?post=1041"}],"version-history":[{"count":1,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1041\/revisions"}],"predecessor-version":[{"id":1042,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1041\/revisions\/1042"}],"wp:attachment":[{"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/media?parent=1041"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/categories?post=1041"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/tags?post=1041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}